Vimta Labs logo

Vimta Labs

VIMTALABS NSE

Key Fundamentals

MicrocapHealthcare TechnologyHealthcare
Market Cap
₹2,792 Cr
Volatility
Moderate
P/E Ratio
35.27
EBITDA
₹90.80 Cr
Return on Equity
12.83%
Debt to Equity
0.01
Book Value
₹102.24
EPS
₹18.53
52W High
₹851
52W Low
₹376.05

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

3
  • Company has reduced debt.
  • Company is almost debt free.
  • Company has delivered good profit growth of 30.0% CAGR over last 5 years

Growth Rate

Revenue Growth
0.22% lower than 3Y
Net Income Growth
-14.94% lower than 3Y
Cash Flow Change
-30.76% lower than 3Y
ROE
-24.97% lower than 3Y
ROCE
-26.21% lower than 3Y
EBITDA Margin (Avg.)
-7.88% lower than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
82
64
73
73
75
85
90
94
98
102
99
109
109
Expenses
58
48
50
47
49
55
57
61
64
68
64
70
72
Operating Profit
24
17
23
26
26
30
33
33
34
34
34
39
37
OPM %
29%
26%
31%
36%
35%
35%
37%
35%
35%
34%
35%
36%
34%
Other Income
1
0
-1
-1
-1
-1
5
2
2
3
0
3
4
Interest
0
1
1
1
0
0
1
0
0
0
0
0
0
Depreciation
8
9
8
8
8
8
10
9
10
10
11
13
13
PBT
16
8
13
16
17
20
28
25
25
26
23
29
28
Tax %
25%
25%
25%
24%
26%
24%
23%
27%
25%
24%
25%
27%
26%
Net Profit
12
6
9
12
12
15
22
18
19
20
18
21
21
EPS in Rs
2.63
1.34
2.14
2.79
2.77
3.44
4.84
4.12
4.24
4.47
3.94
4.73
4.71
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
116
138
154
183
213
181
209
276
315
289
344
407
419
Expenses
99
119
127
138
155
151
156
196
222
195
222
266
274
Operating Profit
17
19
27
45
58
30
53
80
94
94
122
142
145
OPM %
15%
14%
18%
25%
27%
17%
25%
29%
30%
33%
35%
35%
35%
Other Income
1
1
1
1
2
3
1
0
3
-4
5
7
9
Interest
1
1
2
5
5
4
2
2
3
2
2
1
1
Depreciation
11
10
10
16
20
21
23
23
31
33
35
44
46
PBT
7
8
17
26
35
8
28
55
64
55
90
104
107
Tax %
24%
23%
36%
36%
28%
17%
25%
26%
26%
25%
25%
25%
—
Net Profit
5
6
11
16
25
7
21
41
47
41
67
78
80
EPS in Rs
1.14
1.45
2.4
3.72
5.73
1.57
4.81
9.29
10.68
9.26
15.13
17.35
17.85
Div. Payout %
44%
34%
0%
27%
17%
0%
21%
11%
9%
11%
7%
12%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
4
4
4
4
4
4
4
4
4
4
4
9
Reserves
118
122
132
148
167
169
190
229
276
310
374
448
Borrowings
4
26
44
40
26
32
30
19
15
19
9
3
Other Liabilities
21
23
42
40
40
39
49
54
65
61
79
102
Total Liabilities
146
176
222
232
237
245
273
306
360
394
467
562
Fixed Assets
88
88
88
140
135
131
128
162
168
166
230
305
CWIP
0
6
53
0
4
2
17
0
12
59
38
18
Investments
0
0
0
0
0
6
6
6
6
0
0
2
Other Assets
58
82
80
92
99
105
122
138
174
170
198
237
Total Assets
146
176
222
232
237
245
273
306
360
394
467
562
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
15
-1
24
33
39
24
37
59
87
61
94
147
Investing
-8
-16
-39
-24
-16
-20
-32
-38
-57
-76
-76
-130
Financing
-9
19
13
-8
-23
-1
-5
-16
-11
-2
-16
-10
Net Cash Flow
-1
2
-2
1
1
3
1
5
19
-17
2
7
Free Cash Flow
8
-17
-16
9
23
10
5
20
37
-14
17
47
CFO/OP
96
4
107
86
85
101
84
94
106
81
95
121
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
82
100
101
111
100
117
128
102
93
110
113
95
Inventory Days
158
213
183
209
199
191
140
154
195
260
210
203
Days Payable
66
77
184
148
115
114
139
108
124
87
88
79
Cash Conversion Cycle
174
236
100
172
184
194
128
147
164
283
235
219
Working Capital Days
109
99
22
62
78
64
89
87
78
98
96
83
ROCE %
6%
7%
11%
17%
21%
6%
14%
24%
24%
20%
25%
25%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Vimta Labs insights

53 extracted metrics + investor summaries across FY06–FY27.

Log in — free

Shareholding Pattern

DIIs0.37%Promot.35.67%FIIs4.42%Public25.03%Others34.52%As ofJun 2026

Documents

Frequently Asked Questions about Vimta Labs

What does Vimta Labs Ltd do?
Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider[1]
Where is Vimta Labs Ltd (VIMTALABS) listed?
Vimta Labs Ltd trades as VIMTALABS on the NSE and under code 524394 on the BSE.
Which sector does Vimta Labs Ltd belong to?
Vimta Labs Ltd is classified under the Healthcare sector, in the Healthcare Services industry.
What is the market capitalisation of Vimta Labs Ltd?
Vimta Labs Ltd has a market capitalisation of ₹2,792 Cr, which places it in the Small Cap band.
What is the PE ratio of Vimta Labs Ltd?
Vimta Labs Ltd trades at a PE ratio of 35.27, on earnings per share of ₹18.53, against a book value of ₹102.24 per share.
What is the 52-week high and low of Vimta Labs Ltd?
Over the last 52 weeks Vimta Labs Ltd has traded between ₹376.05 and ₹851.
Does Vimta Labs Ltd pay dividends?
Vimta Labs Ltd has a dividend yield of 0.31%.
What is the Return on Equity (ROE) of Vimta Labs Ltd?
Vimta Labs Ltd reported a return on equity of 12.83%. Its debt-to-equity ratio is 0.01.

Company Information

Incorporated in 1990, Vimta Labs Ltd is a contract research and testing services provider[1]

Website vimta.com
CEO Dr. Sivalinga Prasad Vasireddi
Employees 1,315
Listed 2005-12-15
Face Value ₹ 2
Issued Size 4,46,35,189

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/VIMTALABS.md for Vimta Labs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List